LIVALO® (Pitavastatin). A New Statin approved by the U. S. Food and Drug Administration

In August 03, 2009. The Food and Drug Administration in the U.S. approved LIVALO® (Pitavastatin)for primary hypercholesterolemia and combined Dyslipidemia. Pitavastatin is a fully synthetic statin engineered in Japan by Kowa Pharmaceuticals.
It is a more effective inhibitor of cholesterol production than the statins currently available in the market because of its unique structure. Overall its safety and tolerability are on a par with other normally
prescribed statins.

Sources: Kowa Pharmaceuticals

Related Articles

• Statins - An important group of drugs that lower cholesterol.
• Statins can help prevent a second stroke - Therapy with statins after a first stroke reduces the incidence of a second stroke.
• New vaccine for the treatment of atherosclerosis - Vaccination may be used to combat atherosclerosis in the future.
• What are the main causes of heart disease? - Why inflammation kills and what is the real cause of heart disease.
• Add tomatoes to your low cholesterol diet to help increase your good cholesterol - Eat tomatoes as part of a low cholesterol diet.